Stefanie Sarantopoulos, MD, PhD

Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, NC

Daniel Wolff^1*, Corey Cutler^2,3, Stephanie J. Lee⁴, Iskra Pusic⁵, Henrique Bittencourt⁶, Jennifer White, MD, MSc, FRCPC^7*, Mehdi Hamadani, MD⁸, Sally Arai, MD⁹, Amandeep Salhotra, MD¹⁰, Jose A. Pérez-Simón¹¹, Amin Alousi^12*, Hannah Choe, MD¹³, Mi Kwon¹⁴, Arancha Bermúdez^15*, Inho Kim^16*, Gerard Socié¹⁷, Vedran Radojcic¹⁸, Timothy O'Toole^19*, Chuan Tian^20*, Peter Ordentlich^19*, Zachariah DeFilipp²¹ and Carrie L. Kitko, MD²²

¹University Hospital Regensburg, Regensburg, Germany
²Dana-Farber Cancer Institute, Boston, MA
³Harvard Medical School, Boston, MA
⁴Fred Hutchinson Cancer Center, Seattle, WA
⁵Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁶CHU Sainte-Justine, Montreal, Canada
⁷The University of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada
⁸Division of Hematology and Oncology, The Medical College of Wisconsin Inc, Milwaukee, WI
⁹Stanford Health Care, Stanford, CA
¹⁰Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹¹Department of Hematology, Hospital Universitario Virgen del Rocío Instituto de Biomedicina de Sevilla (IBIS), CSIC, University of Sevilla, Sevilla, Spain
¹²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³The James Cancer Hospital Solove Research Institute and The Ohio State University Wexner Medical Center, Columbus, OH
¹⁴Hospital General Universitario Gregorio Marañón, Madrid, Spain
¹⁵Department of Hematology, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain
¹⁶Seoul National University Hospital College of Internal Medicine, Seoul, Korea, Republic of (South)
¹⁷Hopital St. Louis, Department of Hematology - BMT, Paris, France
¹⁸Syndax Pharmaceuticals, Inc., Waltham, MA
¹⁹Syndax Pharmaceuticals, Inc, Waltham, MA
²⁰Incyte, Wilmington, DE
²¹Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA
²²Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University, Nashville, TN

Betty Pace

Augusta University, Augusta, GA

Pamela Y Ting, PhD¹, Sneha Borikar^1*, John Ryan Kerrigan^1*, Noel M Thomsen^1*, Eamon Aghania^1*, Amelia E Hinman^1*, Nicolas Pizzato^2*, Alejandro Reyes^2*, Barna D Fodor^2*, Fabian Wu^2*, Muluken S Belew, PhD^1*, Xiaohong Mao^1*, Jian Wang^1*, Shripad Chitnis^1*, Peter Ashcroft^2*, Wei Niu^1*, Amanda Hachey^1*, Jennifer S Cobb^1*, Nikolas A Savage^1*, Ashley Burke^1*, Joshiawa Paulk^1*, Dustin Dovala^3*, James Lin^3*, Matthew C Clifton^3*, Elizabeth Ornelas^3*, Xiaolei Ma^3*, Nathaniel F Ware^1*, Carina C Sanchez^1*, Remi Terranova^2*, Judith Knehr^2*, Marc Altorfer^2*, S. Whitney Barnes^4*, John Taraszka^1*, Danuta Lubicka^1*, James R Manning^3*, Sonia R Miranda^5*, Rohan EJ Beckwith^1*, Jonathan M Solomon^1*, William Forrester^1*, Gregory Hollingworth^2*, Natalie A Dales^1*, Andrew W Patterson^1*, Tewis Bouwmeester^2*, Juergen Wagner^2*, Glenn Dranoff^1*, Susan C Stevenson^1* and James E Bradner¹

¹Novartis Institutes for BioMedical Research, Cambridge, MA
²Novartis Institutes for BioMedical Research, Basel, Switzerland
³Novartis Institutes for BioMedical Research, Emeryville, CA
⁴Novartis Institutes for BioMedical Research, San Diego, CA
⁵Novartis Institutes for BioMedical Research, East Hanover, NJ

Stephanie Halene, MD

Section of Hematology, Yale Univ. School of Medicine, New Haven, CT

Salima Benbarche, PhD^1*, Jose Maria Bello Pineda^2*, Laura Baquero Galvis^3*, Bo Liu^4*, Jeetayu Biswas^4*, Eric Wang, PhD⁵, K. Ashley Lyttle^4*, Alexander M. Lewis^4*, Martina Sarchi, MD, PhD^6*, Sanjoy Mehta^4*, Ralph Garippa^1*, Juliana Ortiz-Pacheco^4*, Zhuoning Li^4*, Mara Monetti^4*, Robert Stanley, MD, PhD^4*, Sergei Doulatov, PhD⁶, Robert K. Bradley, PhD⁷ and Omar Abdel-Wahab, MD⁸

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Fred Hutchinson Cancer Research Center, Seattle
³University of Washington, Seattle
⁴Memorial Sloan Kettering Cancer Center, New York
⁵The Jackson Laboratory For Genomic Medicine, Farmington, CT
⁶Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
⁷Department of Genome Sciences, University of Washington, Seattle, WA
⁸Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY

Peter M. Voorhees, MD

Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC

Francesca Gay, MD, PhD^1,2, Wilfried Roeloffzen, MD, PhD^3*, Meletios A. Dimopoulos, MD, PhD⁴, Laura Rosiñol, MD, PhD^5*, Marjolein van der Klift, MD, PhD^6*, Roberto Mina, MD^1,2*, Albert Oriol Rocafiguera, MD^7*, Eirini Katodritou, MD^8*, Ka Lung Wu, MD, PhD⁹, Paula Rodriguez Otero, MD, PhD^10*, Roman Hajek, MD^11,12, Elisabetta Antonioli, MD^13*, Mark van Duin, PhD^14*, Mattia D'Agostino, MD^1,2*, Joaquin Martinez-Lopez, MD, PhD^15*, Elena M. van Leeuwen-Segarceanu, MD, PhD^16*, Paola Tacchetti, MD, PhD^17*, Niels W.C.J. van de Donk, MD, PhD¹⁸, Katja Weisel, MD¹⁹, Luděk Pour, MD^20*, Jakub Radocha, MD, PhD²¹, Angelo Belotti, MD^22*, Fredrik Schjesvold, MD, PhD^23,24, Joan Bladé, MD, PhD^25*, Hermann Einsele, MD, PhD^26*, Pieter Sonneveld, MD, PhD¹⁴, Mario Boccadoro, MD²⁷ and Annemiek Broijl, MD, PhD²⁸

¹Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
²Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
³University Medical Center Groningen, Groningen, Netherlands
⁴Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
⁵Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
⁶Department of Internal Medicine, Amphia Hospital, Breda, Netherlands
⁷Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
⁸Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
⁹ZNA Stuivenberg, Antwerp, Belgium
¹⁰Clínica Universidad de Navarra, Pamplona, Spain
¹¹Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
¹²Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
¹³Hematology Unit, AOU Careggi, Florence, Italy
¹⁴Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹⁵Hematology Department, Hospital Universitario 12 de Octubre, Medicine Department Complutense University, CNIO, Madrid, Spain
¹⁶Department of Hematology, St. Antonius Hospital, Nieuwegein, Netherlands
¹⁷IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
¹⁸Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands
¹⁹Department of Oncology, Hematology and BMT, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
²⁰Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
²¹4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
²²Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
²³Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
²⁴KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway
²⁵Hematology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain
²⁶Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
²⁷European Myeloma Network, EMN, Italy
²⁸Erasmus MC Cancer Institute, Rotterdam, Netherlands

Trista E. North, PhD

Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA

Brian Krum, MSc^1*, Noah Huerta^2*, Victoria Chiou^3*, Robert Welner, PhD⁴, Sweta B Patel, PhD^5*, Travis Nemkov, PhD^6* and Anna E Beaudin, PhD⁷

¹Department of Pathology, University of Utah, Cottonwood Heights, UT
²Molecular Medicine, University of Utah, Salt Lake City
³University of Utah, Salt Lake City
⁴Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
⁵University of Colorado School of Medicine, Aurora, CO
⁶University of Colorado Anschutz Medical Campus, Aurora, CO
⁷Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT

Isaac Odame, MD

The Hospital For Sick Children, University of Toronto, Toronto, ON, Canada

Banu Aygun, MD¹, Adam C. Lane, PhD^2*, Luke R. Smart, MD², Leon Tshilolo^3*, Thomas N. Williams^4*, Peter Olupot-Olupot, MD^5*, Brigida Santos, MD^6*, Susan E. Stuber, MA^2*, George A. Tomlinson, PhD^7*, Teresa S. Latham, MA^2* and Russell E. Ware, MD, PhD²

¹Division of Pediatric Hematology/Oncology and Cellular Therapy, Cohen Children's Medical Center, New Hyde Park, NY
²Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
³Centre Hospitalier Monkole, Kinshasa, Congo (The Democratic Republic of the)
⁴KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
⁵Mbale Clinical Research Institute, Mbale, Uganda
⁶Hospital Pediatrico David Bernardino, Luanda, Angola
⁷Toronto General Hospital Eaton North Wing, Toronto, ON, CAN